Plavix market heats up

The country's generic makers will be in a fierce race to snatch up a bigger market share of Plavix (clopidogrel bisulfate) as chemically modified drugs developed by Chong Kun Dang and Daewoong have been eligible for national health insurance.

Despite the fact that the insurance prices for Chong Kun Dang Pharmaceutical's Prigrel and Daewoong Pharm's Vixgrel are determined at 68 percent of an ...